The WN45447 study aims to determine if an experimental drug can help slow down Alzheimer’s disease. WN45447 will include approximately 800 adults who have a recent diagnosis of mild cognitive impairment or mild dementia due to Alzheimer’s disease. Mild cognitive impairment means having problems with memory and thinking skills that are unlike usual age-related changes.
WN45447 Study (Trontier 2)
Dementia and cognitive impairmentClosed to recruitment
